AQ
Aquarius Surgical Technologies Inc.
AQQRF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $165.3K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
138.1% upside
Current Price
$0.0042
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AQQRF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
81 /100
Cheap P/S 1.80x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 34.71%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 53.42%
Net margin 1,654.78%
FCF margin 95.97%
Quality
1 /100
Poor ROIC 45.04%
ROA 79.62%
Asset turnover 0.05x
Debt
0 /100
High Current ratio 0.05x
Int. coverage -4.22x
Debt/Equity N/A
Stability
36 /100
Moderate Beta 1.51x
Rev. volatility 28.79%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AQQRF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Lorne Stewart MacFarlane
Employees
3
Headquarters
Toronto